BATS BZX Real-Time Price
As of 9:33am ET
| +0.03 / +1.99%|
The 2 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +224.68% increase from the last price of 1.54.
The current consensus among 3 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.